# Lemborexant Augmentation of Naltrexone for Alcohol Craving and Sleep

> **NCT05458609** · PHASE3 · COMPLETED · sponsor: **Baylor College of Medicine** · enrollment: 8 (actual)

## Conditions studied

- Alcohol Use Disorder

## Interventions

- **DRUG:** Lemborexant 10 mg
- **DRUG:** Naltrexone

## Key facts

- **NCT ID:** NCT05458609
- **Lead sponsor:** Baylor College of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-02-09
- **Primary completion:** 2024-01-30
- **Final completion:** 2024-01-30
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2026-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05458609

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05458609, "Lemborexant Augmentation of Naltrexone for Alcohol Craving and Sleep". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05458609. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*